Background. In recent years, increasing evidence has accumulated that suggests the majority of cases of genital ulcer disease in sub-Saharan Africa are due to viral and not bacterial infections. Although many cross-sectional studies support such a trend, few serial cross-sectional data are available to show the evolution of genital ulcer disease over time.
Botswana has one of the highest prevalences of HIV infection worldwide. In 1992, the prevalence of HIV infection in antenatal clinics was 18% and reached 37% in 2003 [1] . Several studies have investigated risk factors for HIV infection among adults in sub-Saharan countries; the most important factors include risky sexual behavior, the presence of sexually transmitted diseases (STDs), and noncircumcision in males [2, 3] .
Treatment of STDs has been advocated as an important component of prevention of HIV infection, and many countries have adopted a syndromic approach to the treatment of STDs, using guidelines developed and advocated by the World Health Organization (WHO). However, the success of these programs will depend on whether the treatment is appropriate for the syndrome being observed and treated. There is evidence that the HIV infection epidemic has changed STD epidemiology, with the proportion of cases of genital ulcer disease (GUD) attributable to herpes simplex virus (HSV) type 2 increasing in countries with severe HIV infec-tion epidemics [4] . In South Africa, there was an increase in the proportion of GUD due to HSV-2 from 17% in 1993 to 36% in 1998 [5] . Similar findings have been observed in Durban, where the proportion of ulcers due to HSV-2 increased from 11% in 1991 [4] to 36% in 1994 [6] , and to 48% [7] in 2002.
A study was conducted in 2002 to evaluate the national algorithms for the management of STDs in Botswana. In this article, we present the prevalences of STDs among male and female patients with STDs and women from family planning clinics and compare them to findings from a 1993 survey of a similar population. 1993 Survey. Consecutive patients with STDs and women from family planning clinics were recruited for the study from 12 primary health care government clinics in the city of Gaborone. After consent was obtained, participants underwent a physical examination and were treated for STDs in accordance with syndromic management guidelines. Blood samples and vaginal, cervical, and ulcer swab specimens and urethral swab specimens (men only) were collected. Cervical and urethral swab specimens were cultured for Neisseria gonorrhoeae on modified New York City medium and for Chlamydia trachomatis on cycloheximide-treated McCoy cells. Vaginal swab specimens were cultured for Candida species on Saboraud medium. Bacterial vaginosis was diagnosed on the basis of Gram-stained smear findings [8] . Wet mount and culture on Diamond medium (examined daily for 7 days) was used to detect Trichomonas vaginalis. HIV infection was diagnosed with ELISA (Abbott Laboratories) and confirmed by Western blotting (Immunoblot; Bio-Rad Laboratories). Syphilis was diagnosed on the basis of rapid plasma reagin (Omega Diagnostics) and confirmed by Treponema pallidum haemagglutination assay (Omega Diagnostics). Genital ulcer specimens were cultured for Haemophilus ducreyi on both Mueller-Hinton-based and gonococcal-agar-based media at 35ЊC in a microaerophilic atmosphere. HSV was detected by culture with human embryo lung fibroblast cells in roller tubes. After inoculation, cultures were examined daily for up to 10 days for cytopathic effect. Monolayers exhibiting cytopathic effect were fixed, stained, and examined for syncytia formation and intranuclear inclusion bodies. Ulcer specimens were examined by darkfield microscopy for T. pallidum. Lymphogranuloma venereum was diagnosed on the basis of C. trachomatis isolation from cultures of ulcer specimens and an elevated titer (у1:256) of broadly cross-reacting antibody detected by chlamydial microimmunofluorescence testing. The protocol was approved by the ethics committee of the Botswana Ministry of Health.
METHODS
2002 Survey. The 2002 survey was conducted in the cities of Gaborone, Selebi-Phikwe, and Francistown, Botswana, from November 2001 to February 2002. Three clinics were selected from each city: a primary health care clinic, a 24-h clinic, and a private clinic. Consecutive patients with STDs and women from family planning clinics were recruited. After providing consent, participants completed a standardized questionnaire and were examined and treated by a clinician. Urine, blood, ulcer, and vaginal swab specimens were collected. Patients could decline undergoing a test for detection of HIV and still participate in the survey.
Serum samples were tested for syphilis by rapid plasma reagin (Becton Dickinson) and confirmed by T. pallidum haemagglutination assay (Omega Diagnostics). HIV infection status was determined by ELISA (Abbott Laboratories) and confirmed by a second ELISA (Genelavia; Sanofi Diagnostics Pasteur). Urine specimens were tested for N. gonorrhoeae and C. trachomatis by ligase chain reaction (LCx; Abbott Laboratories). As part of the clinical utility evaluation of a newly developed assay, Mycoplasma genitalium was detected by a research-use only transcription-mediated amplification assay specific for M. genitalium rRNA, using the same assay format used for the CT/NG Aptima Combo 2 assay (Gen-Probe), in accordance with the manufacturer's instructions. Bacterial vaginosis and yeast infection were diagnosed on the basis of findings of Gram-stained smears of vaginal swab specimens. A Nugent score of у7 was considered to be positive for bacterial vaginosis, and the presence of budding yeast was considered to be indicative of yeast infection. A second vaginal swab specimen was used for T. vaginalis culture using the InPouch TV medium (Biomed Diagnostics), which was examined microscopically each day for a week. Blood and urine samples and vaginal swab specimens were processed at the National Reference Laboratory in Gaborone.
Ulcer specimens were tested by multiplex PCR for T. pallidum, H. ducreyi, HSV-1, and HSV-2 at the CDC Laboratory in Atlanta, Georgia. The conditions under which multiplex PCR amplification was performed were the same as those described elsewhere [9] , except that 5 -fluorescence labeled primers were used. Primers were synthesized by the Biotechnology Core Facility at the CDC (Atlanta, GA). The study protocol was approved by the CDC Institutional Review Board and the Health Research Development Committee of the Botswana Ministry of Health.
Data analysis. Data entry was performed with EpiInfo software (CDC), and analyses were performed with SAS software, version 8.01 (SAS Institute). The Yates corrected x 2 test and the 2-tailed Fisher's exact test were used for differences in proportions. Observed prevalences were adjusted for sensitivity and specificity of diagnostic tests according to the following equation [10, 11] :
where P true p true prevalence, P observed p observed prevalence, Se p sensitivity, and Sp p specificity.
Averaged sensitivity and specificity of tests were estimated on the basis of values documented in the literature for symptomatic and asymptomatic populations. The mean values were used to adjust the observed prevalence. Studies that used culture alone as the gold standard were excluded, because the imperfect sensitivity of culture would incorrectly suggest a low specificity for the tests being studied. No adjustment was performed for syphilis serologic findings, bacterial vaginosis, and HIV infection, because tests with a similar performance were used in the 2 surveys. We did not compare the results for candidiasis from both surveys because culture was used in 1993 and Gram staining was used in 2002; culture indicates both infection and colonization, whereas Gram staining has a higher predictive value for active infection. We included M. genitalium in the results for 2002 because it has been recognized as a possible cause of idiopathic cases of urethritis, cervicitis, and pelvic inflammatory disease [12] . Testing for this organism was not available in 1993.
A sensitivity analysis (hereafter referred to as "uncertainty" to avoid confusion with the sensitivity of a test) was performed to take into account the uncertainty of the sensitivity and specificity estimates on the adjusted prevalence and to assess whether our conclusions regarding trends remained valid when different possible values for sensitivity and specificity were used. The range (minimum and maximum) of uncertainty was defined by the lowest and highest estimates of sensitivity or specificity when 11 study was available and by the bounds of the 95% CI when results from only 1 study were available. The range of sensitivity and specificity values ( ) were samn p 500 pled jointly with Latin hypercube sampling (@Risk software; Palisade).
RESULTS
1993 Survey. Of a total of 419 participants, 102 were women practicing family planning, 102 were women with vaginal discharge or lower abdominal pain, 107 were men with urethral discharge, and 108 were patients with GUD (93 men and 15 women). The prevalence of HIV infection was 17% among women practicing family planning, 26% among women with vaginal discharge or lower abdominal pain, 27% among men with urethritis, and 37% among patients with GUD. Prevalences for other sexually transmitted organisms are shown in 2002 Survey. There were a total of 954 participants: 758 women (80%) and 196 men (20%) (table 2). The mean age was 29 years (median age, 27 years). Only 21% were married, but 87% reported a regular sex partner. Of those with a second sex partner, 52% of women and 38% of men reported using a condom during each sex act (table 2) .
Of female participants, 269 were practicing family planning and 489 had STDs (431 patients had vaginal discharge or lower abdominal pain and 58 had GUD). There were 117 male patients with urethral discharge or dysuria and 79 with GUD. Two-thirds of participants consented to HIV testing. Prevalence of HIV infection was 74% among patients with GUD, 62% among men with urethral discharge, 54% among female patients with STDs, and 42% among women practicing family planning. Prevalences of other STDs are presented in table 1.
Of the 137 patients with GUD, 1 (1%) was infected with H. ducreyi, 2 (2%) were infected with T. pallidum, and 80 (58%) were infected with HSV-2. HSV-1 was not detected, and no etiology was established for specimens obtained from 54 patients (39%) . There were no mixed infections. Of patients with a genital ulcer, 7 (5%) had a positive serologic test result for syphilis. The proportion of ulcers caused by HSV-2 ( ) P p .60 and ulcers with unknown etiology ( ) did not vary by P p .11 HIV infection status.
Changes in STD prevalence. Table 3 shows the mean sensitivity and specificity calculated from published estimates and the range (minimum and maximum) of values used in the uncertainty analysis. Table 4 shows the adjusted prevalence and P value for the mean sensitivity and specificity and the results of the uncertainty analysis. From 1993 to 2002, the prevalence of HIV infection increased among all study groups, and the rate of positive serologic test results for syphilis decreased. Decreases in the prevalence of N. gonorrhoeae and C. trachomatis infections were observed among women practicing family planning and female patients with STDs. An increase in the prev- alence of C. trachomatis infection was observed among men, but the increase was not statistically significant ( ). The P p .06 prevalence of T. vaginalis infection also decreased among women practicing family planning, and a nonsignificant trend was observed for symptomatic women.
Among patients with GUD, the proportion of ulcers due to chancroid decreased ( ), whereas the proportion due P ! .0001 to HSV increased ( ) (table 4) . Although the proportion P ! .001 of ulcers due to syphilis was similar in 1993 and 2002, rates of positive serologic test results for syphilis decreased from 52% in 1993 to 5% in 2002 ( ).
The sensitivity analysis shows that the direction of the trends was robust against uncertainty in our estimates of sensitivity and specificity of diagnostic tests. The exception was the prevalence of gonorrhea among men with urethritis, which varied considerably and even overlapped with the uncertainty range.
DISCUSSION
We found changes in the relative prevalence of STDs in Botswana in the past 10 years, with decreases in the prevalence of bacterial STDs and trichomoniasis and increases in the proportion of ulcers due to HSV-2. The prevalence of syphilis and gonorrhea decreased among all study groups; the prevalence of chlamydial infection decreased among female participants; and the prevalence of trichomoniasis decreased among women from family planning clinics. We found that HSV-2 has emerged as the most common cause of GUD and that chancroid and syphilis have become extremely rare. The prevalence of infection with M. genitalium, an organism increasingly recognized as a possible cause of urethritis, cervicitis, and upper reproductive tract disease in women, was higher among symptomatic patients than among women practicing family planning. Previous studies in the region have reported a prevalence of 17% among men with urethritis [34] and 16% among women with endometritis [35] .
Changes in the etiology of GUD are not specific to Botswana. Increases in the proportion of ulcers due to herpes simplex virus have also been observed in a few locations in southern Africa where longitudinal data is available [4] [5] [6] [7] . Furthermore, many countries in Africa have reported HSV-2 as an important cause of genital ulcers [4] . Surveillance reports of STDs from Botswana do not suggest overall increases in the total number GUD cases in the country; 35,000 GUD cases were reported in 1994, compared with 26,000 in 2001 [36] . Syphilis seroprevalence decreased among all study groups. The striking decreases in the prevalence of syphilis are supported by findings from antenatal syphilis testing for 1992-2002 in Francistown, Botswana. A recent study reports that the proportion of positive serologic test results for syphilis among pregnant women decreased from 12.4% in 1992 to 4% in 2003 [37] . Decreases in the seroprevalence of syphilis have also been reported in the region [38] [39] [40] [41] [42] .
Several explanations have been proposed for the apparent changes in the etiology of STDs, including the following: HIVattributable mortality among high-risk groups, behavioral changes, improved syndromic management, increases in antibiotic use, and changes in laboratory techniques. Because individuals with chancroid are likely to have behaviors with higher risks and are more likely to be exposed to HIV as the 99.0 (99.6-100.0) [9] a Values provided in parentheses are 95% CIs. Min, minimum; max, maximum.
epidemic progresses, the differential mortality associated with AIDS might disproportionately affect the prevalence of chancroid, which heavily relies on core groups to persist. On the contrary, because of its longer duration of infection, HSV-2 does not rely on individuals at high risk to spread and is, therefore, less influenced by the differential mortality associated with AIDS [43, 44] . Syndromic management was implemented in Botswana in 1992, and widespread use of antibiotics, together with mandatory serological testing for syphilis, may have contributed to a decrease in the prevalence of syphilis and other STDs. Our findings may also reflect changes in the accuracy of detection caused by improved diagnostic methods, such as PCR. However, after adjusting prevalence estimates for the sensitivity and specificity of laboratory techniques, the changes in prevalence were still significant. Mathematical modeling suggests that behavioral change might be the most important contributor to the observed changes in the prevalence of STDs in Africa [43] . Data from the Family Health Survey conducted in 1988 and the Botswana AIDS Impact Survey conducted in 2001 suggest changes in sexual behavior in the last decade. The median age of first intercourse has increased from 17 to 19 years among women [45, 46] . The rate of teenage pregnancy decreased among girls aged 15-19 years from 8.2% in 1992 to 5.6% in 2001 [45, 46] . The 2001 Botswana AIDS Impact Survey report also reveals a low number of sex partners, with 89% of women and 75% of men reporting only 1 sex partner during the year before completing the survey. Among sexually active participants, 89% of men and 75% of women reported using a condom during the most recent sex act with a nonmarital sex partner. In addition, free condom distribution through the Ministry of Health has increased from 1.3 million condoms in 1998 to 21.4 million in 2002 [37] .
Our study had some limitations. The data collected at STD clinics reflects a relative prevalence of specific etiologies and not a true population prevalence. Because serologic testing for HSV-2 was not available, it was not possible to evaluate changes in the absolute prevalence of HSV-2 infection. This analysis was based on 2 cross-sectional studies conducted with different laboratory techniques, in different clinics, at different points in time, which could account for some of the differences observed in prevalence between 1993 and 2002. There were no demographic and behavioral data available for the 1993 survey. The sensitivity of diagnostic tests might be different for symptomatic and asymptomatic populations; however, most of the studies available regarding performance of diagnostic tests included symptomatic individuals.
The lack of a specific etiology for one-half of the patients with genital ulcers in 1993 and for one-third of such patients in 2002 may be explained by the following: collection of ulcer specimens late in the clinical episode, when an organism is no longer present; ulcers that are caused by an infectious agent for which we did not test; and sample collection or transportation errors. Increased attention has been given to HSV-2 as a cofactor for HIV infection and the role that treatment of HSV infection may have as an HIV transmission prevention strategy. More than 30 studies have demonstrated that HSV-2 infection is a risk factor for HIV acquisition; a meta-analysis of the published studies has shown an overall relative risk of 2.1 [47] . There is also evidence that HSV-2 can increase infectiousness among HIV-infected individuals; several studies have shown that HIV can be isolated from genital ulcer specimens [48] [49] [50] . Previous WHO guidelines for the treatment of GUD were concerned with bacterial etiologies and provided no suggestions for effective therapy for genital herpes. Because of the observed increases in the prevalence of HSV-2 infection worldwide, WHO now recommends administering antiherpes therapy to patients with GUD in places where the relative prevalence of HSV-2 infection is 130% [51] . Countries guided by the predominance of HSV-2 as the major etiologic agent of genital ulcers are likely to change syndromic guidelines to include acyclovir as part of the treatment for GUD. Substantial investment will be needed to add acyclovir to their essential drug list, and few data regarding its effect on clinical course and its cost-effectiveness are available to support this decision. Herpes is a recurrent viral disease, and there is no known cure for it; the course of symptoms can be modified by therapy with acyclovir or its analogues if such treatment is started during the prodrome or within 24 h after the onset of lesions. However, it is not clear whether any clinical benefit will be achieved under real-life conditions, in which there will likely be a delay in symptom recognition and treatment initiation. There is a need to closely monitor the incorporation of antiherpetic treatment into syndromic management, to assess whether it will provide clinical benefit. Given that HSV-2 is the leading cause of GUD in the developing world, if treatment is found to be beneficial, its incorporation into syndromic management could hold great importance for public health, by providing a safe, acceptable, and cost-effective method to treat GUD and potentially reduce HIV infectiousness among HIV-infected persons. Studies to determine the appropriateness of episodic acyclovir therapy for HSV infection in the developing world are urgently needed.
